TZ

Todd C. Zion

AB Akston Biosciences: 20 patents #1 of 5Top 20%
SM Smartcells: 19 patents #1 of 11Top 10%
MIT: 3 patents #1,739 of 9,367Top 20%
Eastman Kodak: 2 patents #3,607 of 8,114Top 45%
N( National Institutes Of Health (Nih): 1 patents #17 of 124Top 15%
NS Nexpress Solutions: 1 patents #124 of 254Top 50%
📍 Marblehead, MA: #5 of 401 inventorsTop 2%
🗺 Massachusetts: #1,251 of 88,656 inventorsTop 2%
Overall (All Time): #55,067 of 4,157,543Top 2%
49
Patents All Time

Issued Patents All Time

Showing 26–49 of 49 patents

Patent #TitleCo-InventorsDate
9579391 Conjugate based systems for controlled drug delivery Thomas M. Lancaster 2017-02-28
9463249 Crystalline insulin-conjugates Thomas M. Lancaster 2016-10-11
9265838 Conjugate based systems for controlled drug delivery Thomas M. Lancaster 2016-02-23
9114176 Exogenously triggered controlled release materials and uses thereof Thomas M. Lancaster 2015-08-25
9095623 Terminally-functionalized conjugates and uses thereof Thomas M. Lancaster 2015-08-04
9074015 Recombinantly expressed insulin polypeptides and uses thereof Thomas M. Lancaster, Sylaja Murikipudi, Rassol Laleau 2015-07-07
9068013 Recombinant lectins, binding-site modified lectins and uses thereof Thomas M. Lancaster, Robert Butters, Naomi Choodnovskiy 2015-06-30
9050370 Conjugate based systems for controlled drug delivery Thomas M. Lancaster 2015-06-09
8940690 Synthetic conjugates and uses thereof Thomas M. Lancaster 2015-01-27
8933207 Drug-ligand conjugates, synthesis thereof, and intermediates thereto Zhiyu Chen, Thomas M. Lancaster 2015-01-13
8906850 Crystalline insulin-conjugates Thomas M. Lancaster 2014-12-09
8846103 Exogenously triggered controlled release materials and uses thereof Thomas M. Lancaster 2014-09-30
8729242 Methods for reducing the mitogenicity of lectin compositions Thomas M. Lancaster, Wenyi Cai, Ryan Faucette, Matthew Pecukonis 2014-05-20
8697643 Method for controllably releasing a drug conjugate within subcutaneous tissue in response to the local concentration of an indicator Thomas M. Lancaster, Matthew Nalewanski 2014-04-15
8623345 Terminally-functionalized conjugates and uses thereof Thomas M. Lancaster 2014-01-07
8603529 Polynucleotide aptamer-based cross-linked materials and uses thereof Thomas M. Lancaster 2013-12-10
8569231 Soluble non-depot insulin conjugates and uses thereof Thomas M. Lancaster 2013-10-29
8357400 Stimuli-responsive systems for controlled drug delivery Jackie Y. Ying, Andrey Zarur 2013-01-22
8062668 Stimuli-responsive systems for controlled drug delivery Jackie Y. Ying, Andrey Zarur 2011-11-22
7687608 Methods for reducing the mitogenicity of lectin compositions Thomas M. Lancaster, Wenyi Cai, Ryan Faucette, Matthew Pecukonis 2010-03-30
7531191 Stimuli-responsive systems for controlled drug delivery Andrey Zarur, Jackie Y. Ying 2009-05-12
6482562 Toner particles of controlled morphology Matthew Ezenyilimba, Michael T. Regan, Dennis E. Smith, Hichang Yoon 2002-11-19
6380297 Polymer particles of controlled shape Dennis E. Smith, Hichang Yoon, Matthew Ezenyilimba 2002-04-30
5936031 Preparation of polyalkylsilsesquioxane particles Paul E. Woodgate, Peter J. Makarewicz 1999-08-10